Commonwealth Equity Services’s Madrigal Pharmaceuticals MDGL Stock Holding History

Commonwealth Equity Services's MDGL Position: Q2 2026 in Review

Commonwealth Equity Services increased its Madrigal Pharmaceuticals (MDGL) stake by 1.9% in Q2 2026, buying an estimated $15.9K and bringing the position to 1,621 shares worth $870K. The position accounts for ﹤0.01% of the portfolio, ranked #2814.

Commonwealth Equity Services first reported a position in MDGL in Q1 2015 and has held it in 13 quarters since. The position peaked at $1.36M in Q4 2025. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

• Commonwealth Equity Services held 1,621 shares of Madrigal Pharmaceuticals worth $870K as of Q2 2026.
• Commonwealth Equity Services bought 31 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $15.9K.
• Madrigal Pharmaceuticals made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #2814 holding.
• Commonwealth Equity Services first reported a position in Madrigal Pharmaceuticals in Q1 2015 and has held it in 13 quarters since.
• Commonwealth Equity Services's Madrigal Pharmaceuticals position peaked at $1.36M in Q4 2025.
• 414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.